{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:02:04Z","timestamp":1775833324763,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018409","name":"Bundesministerium f\u00fcr Gesundheit und Frauen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127644","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:31:46Z","timestamp":1755808306000},"page":"127644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Implementation of smartphone application for reporting adverse events following immunization by the treating doctors in tertiary care teaching hospitals in Chennai, India: Pilot and feasibility study"],"prefix":"10.1016","volume":"63","author":[{"given":"Vinay Kumar","family":"Krishnamurthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-511X","authenticated-orcid":false,"given":"Kumaravel","family":"Ilangovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saradha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravichandran","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rema","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhageerathi","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Manjunathaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkumar","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudharshini","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaiganesh","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthi","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandhini","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Polpakkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Selvavinayagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritu Munshiram","family":"Dhalaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2025.127644_bb0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s13312-013-0210-1","article-title":"Adverse event following immunization (AEFI) surveillance in India: position paper of Indian academy of pediatrics, 2013","volume":"50","author":"Chitkara","year":"2013","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2025.127644_bb0010","article-title":"Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events","volume":"31","author":"Chandler","year":"2019","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127644_bb0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: an overview","volume":"9","author":"Dub\u00e9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127644_bb0020","first-page":"491","article-title":"A brief history of vaccines & vaccination in India","volume":"139","author":"Lahariya","year":"2014","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0025","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1186\/s12889-021-11745-1","article-title":"Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases","volume":"21","author":"Azarpanah","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127644_bb0030","article-title":"Covid-19: India is at Centre of global vaccine manufacturing, but opacity threatens public trust","volume":"28","author":"Thiagarajan","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12913-022-08133-9","article-title":"Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi state, Nigeria: a qualitative study","volume":"22","author":"Omoleke","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2025.127644_bb0040","unstructured":"Immunization safety surveillance\u00a0: guidelines for immunization programme managers on surveillance of adverse events following immunization. 3rd ed. [Internet]. World Health Organization; 2015 [cited 2024 Feb 6]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789290617457."},{"key":"10.1016\/j.vaccine.2025.127644_bb0045","series-title":"Ministry of Health and Family Welfare, Government of India","article-title":"Adverse Events Following Immunization: Surveillance and Response - Operational Guidelines","year":"2015"},{"key":"10.1016\/j.vaccine.2025.127644_bb0050","series-title":"Ministry of Health and Family Welfare, Government of India","author":"Adverse Events Following Immunization: Surveillance and Response - Operational Guidelines","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127644_bb0055","author":"Global vaccine action plan 2011\u20132020 [Internet]"},{"key":"10.1016\/j.vaccine.2025.127644_bb0060","unstructured":"Global Vaccine Safety Blueprint 2. 0 (GVSB2. 0) 2021-2023. 1st ed. Geneva: World Health Organization; 2021. 1 p."},{"key":"10.1016\/j.vaccine.2025.127644_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100362","article-title":"Post-marketing safety surveillance of the rotavirus vaccine in India","volume":"15","author":"Kang","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2025.127644_bb0070","series-title":"A multi-centre, post-marketing surveillance study of Vi polysaccharide\u2013tetanus toxoid conjugate vaccine (Typbar TCV\u00ae) in India. Hum Vaccines Immunother [Internet]","author":"Reddy","year":"2022"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127644_bb0075","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/14740338.2016.1194823","article-title":"Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention","volume":"15","author":"Moro","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127644_bb0080","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jsps.2022.10.001","article-title":"Vaccine adverse event reporting system (VAERS): evaluation of 31 years of reports and pandemics\u2019 impact","volume":"30","author":"Almadani","year":"2022","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.vaccine.2025.127644_bb0085","article-title":"Surveillance of adverse events following immunisation in Australia annual report, 2021","author":"Glover","year":"2024","journal-title":"Commun Dis Intell [Internet]"},{"issue":"49","key":"10.1016\/j.vaccine.2025.127644_bb0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.15585\/mmwr.mm7249a2","article-title":"Progress in immunization safety monitoring \u2014 worldwide, 2020\u20132022","volume":"72","author":"Blau","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127644_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12098-017-2532-9","article-title":"Vaccine safety and surveillance for adverse events following immunization (AEFI) in India","volume":"85","author":"Joshi","year":"2018","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.vaccine.2025.127644_bb0100","series-title":"Immunization technical support unit, ministry of health & family welfare, government of india. [Internet]","author":"Adverse Events Following Immunization (AEFI) Secretariat","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127644_bb0105","author":"Health and Family Welfare Department. Policy Note 2024\u20132025. Demand No. 19. Ministry of Health and Family Welfare, Government of Tamil Nadu. [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0110","first-page":"44","article-title":"Surveillance of adverse events following immunization (AEFI) following routine immunization in Tamil Nadu","volume":"4","author":"Krishnamurthy","year":"2024","journal-title":"Tamil Nadu J Public Health Med Res"},{"key":"10.1016\/j.vaccine.2025.127644_bb0115","author":"Surveillance and Adverse Events Following Vaccination (SAFE-VAC) Portal, Ministry of Health and Family Welfare, Government of India [Internet]"},{"key":"10.1016\/j.vaccine.2025.127644_bb0120","author":"Covid Vaccine Intelligence Network (Co-WIN)- SAFE-VAC Portal, Ministry of Health and Family Welfare, Government of India. [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127644_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/ijp.IJP_53_19","article-title":"Vaccine pharmacovigilance in India: current context and future perspective","volume":"51","author":"Meher","year":"2019","journal-title":"Indian J Pharm"},{"key":"10.1016\/j.vaccine.2025.127644_bb0130","series-title":"National AEFI secretariat, Immunization Technical Support Unit, Ministry of Health and Family Welfare, Government of India","author":"Demonstration of Model AEFI Surveillance Processes in Selected Districts, India","year":"2020"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127644_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-023-04555-3","article-title":"Adverse events following immunization- the known unknowns and black box: based on 10th Dr. I. C. Verma excellence award for young pediatricians delivered as oration on 9th Oct. 2022","volume":"90","author":"Das","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MLR.0000000000001664","article-title":"Guidelines for designing and evaluating feasibility pilot studies","volume":"60","author":"Teresi","year":"2022","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-019-0499-1","article-title":"Guidelines for reporting non-randomised pilot and feasibility studies","volume":"114","author":"Lancaster","year":"2019","journal-title":"Pilot Feasibility Stud"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127644_bb0150","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.vaccine.2021.06.052","article-title":"Understanding reporting practices and perceptions of barriers in adverse events following immunisation surveillance: a cross\u2013sectional survey of paediatricians in Kerala","volume":"39","author":"Thomas","year":"2021","journal-title":"India Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127644_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12553-016-0134-6","article-title":"Mobile application an approach to enhance easy adverse drug reactions reporting in India","volume":"6","author":"Kuchya","year":"2016","journal-title":"Heal Technol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127644_bb0160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12098-015-1844-x","article-title":"How a new health intervention affects the health systems? Learnings from pentavalent vaccine introduction in India","volume":"83","author":"Lahariya","year":"2016","journal-title":"Indian J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1062860618781920","article-title":"Introduction of a Mobile adverse event reporting system is associated with participation in adverse event reporting","volume":"34","author":"Rubin","year":"2019","journal-title":"Am J Med Qual"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127644_bb0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40264-020-00925-4","article-title":"Enhancing pharmacovigilance in sub-Saharan Africa through training and mentoring: a GSK pilot initiative in Malawi","volume":"43","author":"Jusot","year":"2020","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127644_bb0175","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.4103\/jfmpc.jfmpc_1577_24","article-title":"Effectiveness of mobile and e-mail-based reporting on consistency in private health facilities for the disease surveillance system, Poonamallee Health District, Tamil Nadu, India: a parallel group, exploratory randomized open trial","volume":"14","author":"Stanislaus","year":"2025","journal-title":"J Family Med Prim Care"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127644_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13312-014-0360-9","article-title":"Improving AEFI surveillance in India","volume":"51","author":"Mahajan","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2025.127644_bb0185","author":"Adult BCG Vaccine-Reporting of AEFI | Knowledge Base [Internet]"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127644_bb0190","first-page":"283","article-title":"Contribution of medical colleges to tuberculosis control in India under the revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead","volume":"137","author":"Sharma","year":"2013","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127644_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/ijph.ijph_1600_22","article-title":"Collaboration with medical colleges and public health institutions for implementation of national health programs: the way forward","volume":"67","author":"Rasania","year":"2023","journal-title":"Indian J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127644_bb0200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4103\/ijcm.ijcm_712_23","article-title":"Integration of medical colleges under National Tobacco Control Program\u2014a Public Health Priority","volume":"49","author":"Gupta","year":"2024","journal-title":"Indian J Community Med"},{"key":"10.1016\/j.vaccine.2025.127644_bb0205","doi-asserted-by":"crossref","unstructured":"Omoleke SA, Bamidele M, De Kiev LC. Barriers to optimal AEFI surveillance and documentation in Nigeria: Findings from a qualitative survey. James PB, editor. PLOS Glob Public Health. 2023 Sept 8;3(9):e0001658.","DOI":"10.1371\/journal.pgph.0001658"},{"key":"10.1016\/j.vaccine.2025.127644_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.29245\/2578-3009\/2018\/si.1112","article-title":"Vaccine safety and pharmacovigilance in the African region: recent updates","volume":"1","author":"Akanmori","year":"2018","journal-title":"J Immunol Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127644_bb0215","first-page":"89","article-title":"Ratan Tata and a new Car: bill gates and newer vaccines","volume":"11","author":"Banerjee","year":"2018","journal-title":"Med J Dr Patil Univ"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127644_bb0220","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/epidemiologia2030032","article-title":"Addressing different needs: the challenges faced by India as the largest vaccine manufacturer while conducting the world\u2019s biggest COVID-19 vaccination campaign","volume":"2","author":"Koller","year":"2021","journal-title":"Epidemiologia"},{"key":"10.1016\/j.vaccine.2025.127644_bb0225","series-title":"Insights from india on expanding global vaccine production | think global health","author":"Yadav P. Council on Foreign Relations","year":"2024"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127644_bb0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/21645515.2019.1682842","article-title":"Towards adult vaccination in India: a narrative literature review","volume":"16","author":"Dash","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127644_bb0235","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1080\/21645515.2019.1692564","article-title":"Adult vaccination in India: status and the way forward","volume":"16","author":"Lahariya","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127644_bb0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/PMRR.PMRR_13_24","article-title":"Need and rationale of the adult immunisation in India: a review","volume":"2","author":"Gupta","year":"2025","journal-title":"Prev Med Res Rev"},{"key":"10.1016\/j.vaccine.2025.127644_bb0245","author":"Bureau TH. Budget 2024 | Government to focus on vaccination against cervical cancer. The Hindu [Internet]"},{"key":"10.1016\/j.vaccine.2025.127644_bb0250","series-title":"Ministry of health and family welfare, government of India. Standard operating procedures for adult BCG vaccination under programmatic implementation study in India [internet]. [object Object]","author":"National Tuberculosis Elimination Program (NTEP)","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127644_bb0255","series-title":"Preliminary findings from a community-based surveillance for adverse events following immunization with BCG vaccine - a poster presentation","author":"Yadav","year":"2024"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127644_bb0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/PMRR.PMRR_111_24","article-title":"Adverse events following equine rabies immunoglobulin administration among category 3 animal bite exposures","volume":"2","author":"Krishnan","year":"2025","journal-title":"Prev Med Res Rev"},{"key":"10.1016\/j.vaccine.2025.127644_bb0265","author":"U-WIN \u092e\u0948\u0902 AEFI \u0915\u0948\u0938\u0947 Report \u0915\u0930\u0947\u0902\u00a0? #uwin #aefi [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127644_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/PMRR.PMRR_18_23","article-title":"Strengthening immunisation Services in India through digital transformation from co-WIN to U-WIN: a review","volume":"1","author":"Karol","year":"2024","journal-title":"Prev Med Res Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:52:25Z","timestamp":1765857145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"alternative-id":["S0264410X25009417"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127644","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of smartphone application for reporting adverse events following immunization by the treating doctors in tertiary care teaching hospitals in Chennai, India: Pilot and feasibility study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127644"}}